These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 35558512)
1. Long Noncoding RNA MALAT1 and Colorectal Cancer: A Propensity Score Analysis of Two Prospective Cohorts. Li H; Zhang Y; Liu Y; Qu Z; Liu Y; Qi J Front Oncol; 2022; 12():824767. PubMed ID: 35558512 [TBL] [Abstract][Full Text] [Related]
2. High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer. Zheng HT; Shi DB; Wang YW; Li XX; Xu Y; Tripathi P; Gu WL; Cai GX; Cai SJ Int J Clin Exp Pathol; 2014; 7(6):3174-81. PubMed ID: 25031737 [TBL] [Abstract][Full Text] [Related]
3. Prognostic value of long non-coding RNA MALAT1 in cancer patients. Wu Y; Lu W; Xu J; Shi Y; Zhang H; Xia D Tumour Biol; 2016 Jan; 37(1):897-903. PubMed ID: 26254614 [TBL] [Abstract][Full Text] [Related]
4. Dysregulation of MALAT1 and miR-619-5p as a prognostic indicator in advanced colorectal carcinoma. Qiu G; Zhang XB; Zhang SQ; Liu PL; Wu W; Zhang JY; Dai SR Oncol Lett; 2016 Dec; 12(6):5036-5042. PubMed ID: 28101234 [TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA MALAT1 can serve as a valuable biomarker for prognosis and lymph node metastasis in various cancers: a meta-analysis. Shuai P; Zhou Y; Gong B; Jiang Z; Yang C; Yang H; Zhang D; Zhu S Springerplus; 2016; 5(1):1721. PubMed ID: 27777857 [TBL] [Abstract][Full Text] [Related]
6. Role of MALAT1 as a Prognostic Factor for Survival in Various Cancers: A Systematic Review of the Literature with Meta-Analysis. Wei Y; Niu B Dis Markers; 2015; 2015():164635. PubMed ID: 26420912 [TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor 2 hypermethylation in peripheral blood leukocytes and colorectal cancer risk and prognosis: a propensity score analysis. Sun H; Liu Y; Zhang Y; Wang Y; Zhao Y; Liu Y Front Oncol; 2023; 13():971435. PubMed ID: 37213278 [TBL] [Abstract][Full Text] [Related]
8. Clinical prognostic value of metastasis-associated lung adenocarcinoma transcript 1 in various human cancers: an updated meta-analysis. Li Y; Yang Z; Wan X; Zhou J; Zhang Y; Ma H; Bai Y Int J Biol Markers; 2016 May; 31(2):e173-82. PubMed ID: 26847605 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of long noncoding RNA MALAT1 in various carcinomas: evidence from nine studies. Xue Y; Teng YQ; Zhou JD; Rui YJ Tumour Biol; 2016 Jan; 37(1):1211-5. PubMed ID: 26282005 [TBL] [Abstract][Full Text] [Related]
10. Clinicopathological and prognostic significance of long noncoding RNA MALAT1 in human cancers: a review and meta-analysis. Li J; Cui Z; Li H; Lv X; Gao M; Yang Z; Bi Y; Zhang Z; Wang S; Zhou B; Yin Z Cancer Cell Int; 2018; 18():109. PubMed ID: 30093838 [TBL] [Abstract][Full Text] [Related]
11. A genetic variant in long non-coding RNA MALAT1 associated with survival outcome among patients with advanced lung adenocarcinoma: a survival cohort analysis. Wang JZ; Xiang JJ; Wu LG; Bai YS; Chen ZW; Yin XQ; Wang Q; Guo WH; Peng Y; Guo H; Xu P BMC Cancer; 2017 Mar; 17(1):167. PubMed ID: 28253859 [TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 (MALAT1) interacts with estrogen receptor and predicted poor survival in breast cancer. Huang NS; Chi YY; Xue JY; Liu MY; Huang S; Mo M; Zhou SL; Wu J Oncotarget; 2016 Jun; 7(25):37957-37965. PubMed ID: 27191888 [TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA MALAT1 promotes tumour growth and metastasis in colorectal cancer through binding to SFPQ and releasing oncogene PTBP2 from SFPQ/PTBP2 complex. Ji Q; Zhang L; Liu X; Zhou L; Wang W; Han Z; Sui H; Tang Y; Wang Y; Liu N; Ren J; Hou F; Li Q Br J Cancer; 2014 Aug; 111(4):736-48. PubMed ID: 25025966 [TBL] [Abstract][Full Text] [Related]
14. Emerging role of long non-coding RNA MALAT1 in predicting clinical outcomes of patients with digestive system malignancies: A meta-analysis. Wang C; Zhang Q; Hu Y; Zhu J; Yang J Oncol Lett; 2019 Feb; 17(2):2159-2170. PubMed ID: 30719108 [TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA MALAT1 as a potential novel biomarker in digestive system cancers: a meta-analysis. Song W; Zhang RJ; Zou SB Minerva Med; 2016 May; ():. PubMed ID: 27186920 [TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA MALAT1 as a potential novel biomarker in digestive system cancers: a meta-analysis. Song W; Zhang RJ; Zou SB Minerva Med; 2016 Aug; 107(4):245-50. PubMed ID: 27348442 [TBL] [Abstract][Full Text] [Related]
17. High Expression of Long Noncoding RNA MALAT1 Indicates a Poor Prognosis and Promotes Clinical Progression and Metastasis in Bladder Cancer. Li C; Cui Y; Liu LF; Ren WB; Li QQ; Zhou X; Li YL; Li Y; Bai XY; Zu XB Clin Genitourin Cancer; 2017 Oct; 15(5):570-576. PubMed ID: 28648755 [TBL] [Abstract][Full Text] [Related]
18. JMJD2C promotes colorectal cancer metastasis via regulating histone methylation of MALAT1 promoter and enhancing β-catenin signaling pathway. Wu X; Li R; Song Q; Zhang C; Jia R; Han Z; Zhou L; Sui H; Liu X; Zhu H; Yang L; Wang Y; Ji Q; Li Q J Exp Clin Cancer Res; 2019 Oct; 38(1):435. PubMed ID: 31665047 [TBL] [Abstract][Full Text] [Related]
19. MALAT1 sponges miR-106b-5p to promote the invasion and metastasis of colorectal cancer via SLAIN2 enhanced microtubules mobility. Zhuang M; Zhao S; Jiang Z; Wang S; Sun P; Quan J; Yan D; Wang X EBioMedicine; 2019 Mar; 41():286-298. PubMed ID: 30797712 [TBL] [Abstract][Full Text] [Related]
20. Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer. Larsson A; Fridberg M; Gaber A; Nodin B; Levéen P; Jönsson G; Uhlén M; Birgisson H; Jirström K BMC Cancer; 2012 Jul; 12():282. PubMed ID: 22769594 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]